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2ABSTRACT
The side-chain of Val-75 stabilizes the fingers subdomain of the human immunodeficiency 
virus type 1 (HIV-1) reverse transcriptase (RT), while its peptide backbone interacts with 
the single-stranded DNA template (at nucleotide +1) and with the peptide backbone of 
Gln-151.  Specific DNA polymerase activities of mutant RTs bearing amino acid 
substitutions at position 75 (i.e. V75A, V75F, V75I, V75L, V75M, V75S and V75T) were
relatively high.  Primer extension experiments carried out in the absence of one dNTP 
suggested that mutations did not affect the accuracy of the RT, except for V75A, V75F, 
V75I, and in a lesser extent V75T.  The fidelity of RTs bearing mutations V75F and V75I 
increased 1.8- and 3-fold, respectively, as measured by the M13 lacZα forward mutation 
assay, while V75A showed 1.4-fold decreased accuracy.  Steady- and pre-steady-state 
kinetics demonstrated that the increased fidelity of V75I and V75F was related to their 
decreased ability to extend mismatched template-primers, while misincorporation 
efficiencies were not significantly affected by mutations.  The increased mispair extension 
fidelity of mutant V75I RT could be attributed to the nucleotide affinity loss, observed in 
reactions with mismatched template-primers.   Altogether, these data suggest that Val-75 
interactions with the 5´ template overhang are important determinants of fidelity.
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3Introduction
Human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) converts the 
viral genomic RNA to a double-stranded DNA (dsDNA) intermediate which integrates into the 
host genome. RT is a multifunctional enzyme, possessing RNA- and DNA-dependent DNA 
polymerase, RNase H, strand transfer and strand displacement activities.1 The HIV-1 RT is a 
heterodimeric enzyme composed of two subunits of 66 and 51 kDa respectively, with 
subdomains termed fingers, thumb, palm and connection in both subunits and an RNase H 
domain in the larger subunit only.2,3 The DNA polymerase active site resides within the palm 
subdomain of the larger subunit (p66), which contains the essential catalytic aspartic acid 
residues 110, 185 and 186.4,5  Other residues in their vicinity, such as Lys-65, Arg-72, Asp-113, 
Ala-114, Tyr-115 and Gln-151 are involved in the interactions with the incoming dNTP, while 
Leu-74, Pro-157, Phe-160, Tyr-183 and Met-184 could indirectly affect dNTP binding.3
Reverse transcription is error prone and contributes to the high genetic variability of 
retroviruses. Mutation rates in a single cycle of retrotranscription are in the range of 10–4–10–5
misincorporations per nucleotide. One of the consequences of the high mutation rates has been 
the emergence of drug resistant HIV variants. Polymerization errors can be generated either by 
misinsertion of an incorrect nucleotide followed by mispair extension, or by transient primer 
slippage.6  Mutational studies have shown that molecular determinants of nucleotide specificity 
and fidelity of DNA synthesis map within the HIV-1 RT p66 subunit, mostly in the vicinity of 
the dNTP binding site.7,8  Thus, nonconservative amino acid changes affecting Tyr-115, as well 
as the substitutions of Ala for Arg72 or Met184 were shown to reduce the accuracy of the viral 
RT.9-13 On the other hand, several mutations affecting residues that interact with the incoming 
nucleotide (e.g. at positions 65, 151 and 184) increase the accuracy of the viral RT.10,14-17
4Structural determinants of RT fidelity are not restricted to residues close to the 
polymerase active site.  Several amino acid substitutions affecting interactions with nucleotides -
1 and -2 of the primer (e.g. F227A, M230I),16,18-20 or interactions with the template grip (e.g. 
E89K and other amino acid changes at this position),21 as well as amino acid changes involving 
residues that contact the minor groove of the template-primer (e.g. G262A, W266A) were 
shown to decrease the accuracy of the HIV-1 RT.22  In addition, mutations in the primer grip of 
the RNase H domain could also influence fidelity, as demonstrated for the murine leukaemia 
virus RT.23  
Another set of residues that contributes to fidelity of reverse transcription includes amino 
acids that interact with 5´ single-stranded template overhang.  According to the crystal structure 
of the ternary complex of HIV-1 RT●DNA/DNA●dTTP,3 residues 24-27, 30 and 61-63 pack 
against template nucleobases +2 and +3, with Trp-24, Pro-25, Lys-30, Phe-61 and Ile-63 
contributing the largest contact surface.  Residues 72, 74-78 and 81 interact with the template 
nucleotide +1, with Leu-74 and Arg-78 making the largest number of contacts with the 
nucleotide.  Several mutants affecting interactions with the single-stranded template (F61A, 
L74V, D76I, D76R, D76V and R78A) were found to increase fidelity of DNA synthesis, based 
on determinations of steady-state kinetic parameters or mutant frequencies obtained with the 
M13 lacZα forward mutation assay.24-28  However, most of the residues interacting with the 5´ 
template overhang are highly conserved among HIV-1 isolates (http://hivdb.stanford.edu/). 
Drug resistance-related mutations at positions 62 (i.e. A62V), 74 (i.e. L74I and L74V) 
and 77 (i.e. F77L) are likely to emerge after treatment with nucleoside analogue RT inhibitors, 
although codon 75 shows the highest variability under drug pressure.29,30 A62V, V75I, F77L
and F116Y are secondary mutations that together with Q151M confer resistance to multiple 
nucleoside analogues.31,32 V75T was related to low-level resistance to stavudine and other 
dideoxynucleosides33 and V75L has been observed as a secondary mutation in HIV-1 variants 
5resistant to quinoxaline nonnucleoside RT inhibitors.34  Other amino acid substitutions at this 
position (e.g. V75A, V75M and V75S) are also frequently found in patients undergoing therapy 
with RT inhibitors.30
In this work, we have obtained a series of mutant RTs with substitutions at position 75 in 
order to define the role of Val-75 in nucleotide specificity and fidelity of DNA synthesis.  
Mutant RTs with altered fidelity were identified, and kinetic parameters for nucleotide 
incorporation were determined under steady-state and pre-steady-state conditions.  The results 
of misinsertion and mispair extension fidelity assays led to the identification of V75I as a 
substitution increasing the accuracy of the viral RT.  Those data were consistent with the results 
obtained from assays based on the inactivation of the lacZ gene in bacteriophage M13mp2, and 
support the role of the 5´ single-stranded template as an important determinant of fidelity in 
HIV-1 RT.
Results
Effect of amino acid substitutions on DNA polymerase activity
The analysis of published crystal structures of HIV-1 RT reveals that Val-75 is located at 
the base of the fingers subdomain, more than 16 Å away from the catalytic triad of the DNA 
polymerase active site.  In the ternary complex of HIV-1 RT●DNA/DNA●dTTP,3 the distances 
between the Cα atom of Val-75 and the Cα atoms of Asp-110, Asp-185 and Asp-186 are in the 
range of 19.8 – 22.7 Å.  The side-chain of Val-75 is directed towards the hydrophobic core of 
the helices of the fingers subdomain, interacting with Val-60, Lys-73, Phe-77, and Tyr-146.3,35  
The peptide backbone of Val-75 contacts the single-stranded template, through interactions 
between its –CO– group and the nucleotide at position +1, while its –NH– group interacts with 
the peptide backbone of Gln-151.  These observations suggest that amino acid substitutions 
6affecting the side-chain of Val-75 would influence the topology of the RT Cα backbone 
interacting with the 5´ template overhang, while having an effect on nucleotide selectivity.
Mutant RTs containing Ala, Phe, Ile, Leu, Met, Ser or Thr instead of Val-75 were 
obtained as p66/p51 heterodimers and their DNA-dependent DNA polymerase activity was 
determined by using a 47/25-mer heteropolymeric template-primer and dTTP, under steady-state 
conditions.  As shown in Table 1, the introduced mutations produced moderate reductions in the 
catalytic efficiencies of nucleotide incorporation (measured as kcat/Km), in comparison with the 
wild-type enzyme.  While kcat values were similar for all of the mutants tested, differences in the 
catalytic efficiencies resulted from variations in the apparent Km values, which were 2- to 3.8-
fold higher for mutant RTs than for the wild-type enzyme.  
Primer extension assays using deoxynucleotide templates and biased dNTP pools
An initial assessment of the fidelity of mutant HIV-1 RTs was obtained by using an 
assay that monitors primer extension in the absence of one dNTP complementary to template 
nucleotides. Under these conditions, the elongation of the primer past a template nucleotide 
complementary to the excluded dNTP requires the insertion of an incorrect nucleotide and 
further extension of the generated mismatch primer. The results obtained using template-primer 
D2-47/PG5-25 are given in Figure 1. Full primer extensions were obtained with mutant and 
wild-type RTs when all required dNTPs were present in the reaction. Extension efficiencies
were similar for the wild-type enzyme and for mutants V75L, V75M and V75S in all reactions.  
However, different band patterns were observed with mutants V75A, V75F, V75I and V75T.   
In the absence of dATP, the amount of fully extended primers accumulated in reactions 
catalyzed by V75A RT appears to be larger than in reactions catalyzed by the wild-type RT
(Figure 1), particularly after long incubation times (for example, compare the intensities of the 
corresponding smears with those of bands at position +7 for mutant and wild-type RTs). In 
7contrast, the products generated by V75F, V75I and V75T under those conditions were shorter.  
In comparison with the wild-type RT, there was a slower accumulation of fully extended 
products in reactions catalyzed by V75F (see arrows in Figure 1).  This effect was also observed 
with mutants V75I and V75T, although in this case the most significant differences between 
mutants and wild-type RT were detected in reactions incubated during 5 or 15 min, by 
comparing the relative intensities of bands +4 and +7.  Taken together, these results were taken 
as preliminary evidence suggesting that V75F, V75I and V75T RTs were more faithful than the 
wild-type enzyme, while V75A conferred reduced fidelity of DNA synthesis. 
Steady-state fidelity assays 
Misinsertion and mispair extension fidelity assays were used to estimate the accuracy of 
DNA polymerization catalyzed by the wild-type RT and mutants V75A, V75F and V75I.  
Steady-state kinetic parameters for the incorporation of nucleotides at the 3´ end of the primer 
were obtained with the heteropolymeric template-primer D2-47/PG5-25. Misinsertion fidelity 
assays involved kinetics measurements for the incorporation of a correct (T) or an incorrect (A, 
C or G) nucleotide at the 3´end of the primer, and the kinetic parameters, kcat and Km, are given 
in Table 2. All tested RTs misinserted dCTP and dGTP with the highest efficiency, whereas 
there was hardly any extension in the presence of dATP.  Misinsertion ratios determined as the
ratio of the catalytic efficiencies of incorporation of an incorrect dNTP relative to the correct 
dTTP were in the range from 3.1 x 10-5 to 1.8 to 10-4. In general, these values were somewhat 
higher for the mutants than for the wild-type RT, although the largest differences were obtained 
with the mutant V75A, which showed a 5.8-fold higher misinsertion efficiency of dCTP 
incorporation, in comparison with the wild-type enzyme. 
The kinetics of mispair extension were studied for correctly matched base pairs (A:T) 
and for mismatches A:C, A:G and A:A, using the template-primer D2-47/PG5-25 and its 
8corresponding derivatives having primers PG5-25C, PG5-25G and PG5-25A, respectively. In all 
cases, we measured the incorporation of a correct T opposite A at the 3´end of the primer. The 
results are shown in Table 3.  Wild-type RT and the mutant V75A showed relatively small 
differences in their catalytic constants, although extension efficiencies of A:G and A:A mispairs 
were around 2-3 times higher for the mutant than for the wild-type enzyme.  These data were in 
agreement with the lower fidelity displayed by V75A in misincorporation assays.  In contrast, 
mutants V75I and V75F showed mismatch extension ratios that were around 3 to 5 times 
smaller than those obtained with the wild-type RT.  These effects were observed with all three 
mispairs tested, and could be largely attributed to the larger increases in the apparent Km values 
obtained in dTTP incorporation reactions of mismatched template-primers (Table 3).  
Pre-steady-state kinetic analysis of correct and incorrect nucleotide incorporation on 
matched template-primers 
Under the steady-state conditions used Km = Kd(koff/kpol).
36  Therefore, the steady-state 
parameters reported above do not allow for the precise determination of either the Kd for the 
incoming dNTP, nor the rate constant of nucleotide incorporation, kpol, whose values have to be 
obtained from pre-steady-state kinetic experiments. Representative pre-steady-state burst 
experiments for the incorporation of a correct nucleotide (dTTP) on the DNA-DNA template-
primer 31T/21P, by the wild-type RT are shown in Figure 2 (a), left panel.  The rate of 
nucleotide incorporation (kobs) was determined from burst experiments carried out in the 
presence of different concentrations of dNTP.  The biphasic nature of the burst indicates that 
rate-limiting step of the catalytic cycle occurs after chemistry.  The exponential bursts showed a 
fast phase with rates of 3 – 11 s-1, and a slow phase (i.e. steady-state) with rates as high as 0.089 
s-1, consistent with the kcat values reported in Table 1. By analyzing the dependence of the 
reaction rate (kobs) on dNTP concentration, we obtained a measure of both the maximum rate of 
9dNTP incorporation (kpol) and the dNTP binding affinity (Kd) after fitting the data to a 
hyperbolic curve (Figure 2 (b), left panel). Similar experiments were also carried out with the 
mutant enzymes and the dTTP concentration dependence plots are shown in Figure 2 (c), left.  
The pre-steady-state kinetic parameters of nucleotide incorporation, kpol and Kd, are given in 
Table 4. Catalytic efficiencies of correct nucleotide incorporation are similar for all RTs, except 
mutant V75F, whose kpol/Kd value is lower, due to decreased kpol and increased Kd in comparison 
with the wild-type enzyme.  
The kinetics of misincorporation of dCTP and dGTP into the heteroduplex DNA/DNA 
31/21-mer were determined under single turnover conditions (Figure 2), with the enzyme (RT 
120 nM) in slight excess of the template-primer (31T/21P, 100 nM).  Elongation product 
formation was quantified and plotted versus time, and the data for each time course was fit to a 
single exponential to provide the rate of incorporation (Figure 2 (a), center and right panels).  
Kinetic parameters, kpol and Kd were obtained after plotting the first-order rates versus
nucleotide concentration, and fitting the data to a hyperbola (Figure 2 (b),(c)).  Misinsertion 
ratios were in the range of 1.7 x 10-5 to 9.7 x 10-5 for all misincorporations tested, but 
differences among the mutant and wild-type RTs were relatively small.  The only significant 
difference with the wild-type RT was observed with mutant V75I that showed a 2.6-fold 
reduced misinsertion ratio for the incorporation of C instead of T.  As previously described by 
other authors,37,38 large reductions in the catalytic efficiencies of misincorporation of C or G 
opposite A were a consequence of the loss of affinity for the nucleotide binding site and the 
lower incorporation rates (kpol), in comparison with those obtained for the incorporation of the 
correct nucleotide.  However, it should be noted that the low kpol values of nucleotide 
misincorporation may not reflect a true catalytic constant, since the rate of dissociation of the 
RT●DNA●dNTP complex is expected to be high.37,39 Although koffs for the ternary complex 
were not determined, the results of nucleotide incorporation assays carried out with wild-type 
and mutant RTs in the presence of a DNA trap, suggested that the obtained kpols for nucleotide 
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misincorporation were largely influenced by the disruption of the RT●DNA●dNTP complex 
(data not shown).
Pre-steady-state kinetic analysis of nucleotide incorporation on mismatched template-
primers 
The kinetic parameters obtained in the misinsertion experiments described above 
suggested that the misinsertion step does not make a significant contribution to the fidelity 
differences between wild-type and mutant RTs.  Therefore, we examined the pre-steady-state 
kinetics of mismatch extension, a step required for fixation of the mutation. In these 
experiments we analyzed the incorporation of dTTP (a correct nucleotide) onto three different 
mismatched 3´ ends (G:T, G:G and G:A), using template-primers 31T/21PT, 31T/21PG and 
31T/21PA, respectively.  Reaction rate constants (kobs) were determined under single turnover 
conditions and using an excess of enzyme (120 nM) over substrate (31/21-mer, 100 nM), and 
then measuring the products formed at different dTTP concentrations (Figure 3 (a)). The plots of 
the first-order rate constants (kobs) for nucleotide incorporation versus the dTTP concentrations,
obtained wild-type and mutant RTs using different mismatched-template primers are given in 
Figures 3 (b) and 3 (c), respectively.  Table 5 summarizes the kinetic parameters for nucleotide 
incorporation on mismatched template-primers, for all tested RTs.  As expected, all RTs showed 
higher mismatched extension ratios for G:T mispairs than for G:G or G:A mispairs.  
Extension of G:T mispairs by wild-type RT proceeds at a slower rate due to a 5-fold 
reduction in the kpol, while the Kd increases by approximately 200-fold.  These data suggest that 
dNTP binding is responsible for the lower efficiency of G:T mispair extension. As observed in 
the case of nucleotide misincorporation, the lower kpol values could reflect the off-rates for the 
ternary complex RT●DNA●dNTP. Although the dissociation of the ternary complex could 
explain in part the lower rates of dTTP incorporation on G:T mispairs, kpol values were even 
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lower on G:G and G:A mispairs.  These data would be consistent with the formation of a “dead-
end” complex in the presence of G:G and G:A mispairs.39,40  In this scenario, the kinetics of 
mispair extension could reflect the sliding rate of the mismatch between the the pre- and post-
translocated states.
Our results indicate that mispair extension efficiencies of the wild-type RT and the 
mutant V75A were very similar. In contrast, V75F and V75I showed reduced mispair extension 
efficiencies.  In the case of V75I, there was a 3.2-fold reduction of the G:T mismatch extension 
ratio, which resulted from the larger increase in the apparent Kd value (Table 5).  While 
differences in mispair extension efficiencies between wild-type RT and mutant V75A were 
relative small, V75I showed increased fidelity with all three mispairs tested in this assay.  For 
V75F, differences were relatively small, except for G:G mispair extensions, which were 
elongated at a very low rate by this mutant.
M13mp2 lacZα forward and reversion mutation assays 
The influence of amino acid substitutions affecting Val-75 of HIV-1 RT on its mutation 
rate was assessed using and M13-based forward mutation assay with lacZα as a reporter gene.41  
Mutations generated when the RT copies the gapped region of the lacZ gene in M13mp2 can be
scored by the number of plaques with altered colour phenotype (pale blue or colorless) in a 
specific indicator strain. The mutant frequency is then calculated as the ratio of mutant to total 
plaques. The results shown in Table 6 revealed that the wild-type HIV-1 RT was slightly more 
faithful than the RT having mutation V75A.  In contrast, mutant frequencies obtained with 
mutants V75F and V75I were 1.8 and 3.0 times smaller than those obtained with the wild-type 
RT.  The higher fidelity conferred by the substitution of Ile for Val-75 was further confirmed 
using an M13mp2 lacZα reversion mutation assay.   In this assay, the template strand of the 
lacZ gene contains an amber (TGA) codon that inactivates the nonessential α-complementation 
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activity.42  Polymerase errors introduced at this codon may restore the α-complementation 
activity, rendering blue plaques.  The mutant frequency obtained with the wild-type HIV-1 RT 
was around 3.5 times higher than the mutant frequency determined for the mutant V75I RT 
(Table 6), a result broadly in agreement with the data collected from misinsertion and mispair 
extension fidelity assays.
Discussion
The β3-β4 hairpin loop (residues 56-77) of the fingers subdomain in the 66-kDa subunit 
of the HIV-1 RT undergoes a large conformational change upon dNTP binding.3,43  Residues in 
the β3-β4 hairpin loop, which are often involved in nucleoside analogue resistance,44-46 directly 
contact the incoming dNTP as well as indirectly influence its binding via interactions with the 
template base.  The comparison of the crystal structures of HIV-1 RT binary and ternary 
complexes revealed that the 5´ single-stranded template gets closer to the peptide backbone of 
Val-75 in the ternary complex (Figure 4).  Several carbon atoms within the ribose moiety of the 
template nucleotide at position +1 are located less than 4 Å away from the –CO– group of Val-
75,3 with the C1’ atom at a distance of 3.44 Å (Figure 4 (b)).  In contrast, in binary complexes of 
HIV-1 RT and double stranded DNA, there is a larger distance between the ribose moiety of 
template nucleotide +1 and the peptide backbone of Val-75.  Thus, in complexes containing a 
DNA duplex with an overhang of only one nucleotide (e.g. Protein Data Bank file 2HMI), the 
peptide backbone of Val-75 is at 4.29 Å of the C5’ atom of the ribose, while on average the 
ribose ring atoms are more than 5.5 Å away from Val-75 47 (Figure 4 (d)).  A similar topology 
was observed in the binary complex containing an RNA/DNA hybrid with a one-nucleotide 
overhang.48  Interestingly, in an HIV-1 RT/dsDNA binary complex containing a 5´ template 
overhang of 3 nucleotides, the interaction between the –NH– and –CO– groups of the peptide 
backbones of Val-75 and Gln-151 was maintained, but the –CO– group of Val-75 was found to 
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be closer to the nitrogen base of the template nucleotide +1 than to its ribose moiety49 (Figure 4 
(c)).  Taken together, these observations suggested that Val-75 plays a role in positioning the 
template nucleotide +1, once the ternary complex is formed.  In addition, the side-chain of Val-
75 interacts with residues such as Val-60, Phe-77 or Tyr-146, that are important to maintain the 
structure of the fingers subdomain while influencing the architecture of the dNTP binding site.35
The mutational analysis of Val-75 of HIV-1 RT has revealed that this position is rather 
tolerant to change, although some mutations appear to have an influence on nucleotide
specificity and fidelity of DNA synthesis. Thus, substituting Ile or Phe for Val-75 increased the 
accuracy of the polymerase, while the substitution of Ala for Val-75 led to a modest but 
significant reduction of the enzyme’s fidelity.  Interestingly, those effects were consistently 
detected with the different types of assays used: (i) primer extensions in the absence of one 
dNTP, (ii) nucleotide misincorporation and mispair extension under steady-state conditions, (iii) 
nucleotide misincorporation and mispair extension under pre-steady-state conditions, and (iv) 
M13 lacZ-based forward mutation assays.  The largest effects were observed with mutant V75I 
that showed a 3-fold increased accuracy in forward mutation assays.  A similar increase (3.5-
fold) was also obtained with this mutant in a reversion mutation assay.
Mechanistic insights into the role of Val-75 in fidelity of DNA synthesis were obtained 
from kinetic assays.  The events leading to the fixation of a mutation involve nucleotide 
misincorporation, followed by extension of a mispaired template-primer.6-8  Kinetic parameters 
obtained under steady-state conditions showed that the increased fidelity of V75I and V75F was 
a consequence of their lower mispair extension efficiencies in comparison with the wild-type 
RT.  However, a mechanistic interpretation of the data based on the steady-state kinetic 
parameters kcat and Km is problematical due to the fact that Km differences in dNTP binding are 
largely governed by kpol.  Therefore, we performed pre-steady-state kinetic analysis on Val-75 
mutants in order to identify which step was affected in the process leading to the generation of a 
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mutation. As shown in Figure 5, in comparison with the wild-type RT, mutations conferring 
higher accuracy (i.e. V75I and V75F) showed significantly lower mispair extension ratios under 
both steady- and pre-steady-state conditions, without having a large impact on misincorporation.   
Interestingly, the mutant V75I showed G:T, G:G and G:A mispair extension ratios which 
were around 3 to 5 times lower than those obtained with the wild-type RT under pre-steady-state 
conditions.  In comparison with the wild-type enzyme, there was a larger increase in the Kd for 
the correct dNTP, in polymerization reactions carried out with mismatched template-primers 
and mutant V75I (Table 5).  However, both wild-type HIV-1 RT and the mutant V75I showed 
similar catalytic efficiencies for the incorporation of dTTP on matched (G:C) template-primers 
(Table 4), and similar catalytic constants (kpol) for the incorporation of correct dNTPs on 
mismatched 3´ ends (Table 5).  Mutant V75F also showed decreased fidelity, although in this 
case, significant differences were observed only with G:G mispairs (Figure 5).  As in the case of 
V75I, the Kd for the correct nucleotide increased around 5 times, although V75F caused a 
reduction in the kpol for dTTP on G:G mismatched template-primers, which was not significant 
for the mutant having Ile instead of Val-75 (Table 5).  
Although steady-state kinetic analysis has been widely used for analyzing fidelity of 
HIV-1 RT mutants, there are very few pre-steady-state kinetic studies dealing with the effects of 
mutations on fidelity of DNA synthesis.  Thus, Feng and Anderson38 analyzed the effects of the 
lamivudine-resistance mutation M184V in misinsertion fidelity assays.  Authors showed that 
this mutation had a relatively small effect on the RT’s ability to discriminate between correct 
and incorrect nucleotides.  Similar studies carried out with the single-amino acid variants V148I 
and Q151N revealed only small differences in nucleotide selectivity between both mutants and 
the wild-type RT, although V148I and Q151N showed reduced mispair extension efficiency in 
comparison with the wild-type RT.50  In the case of Q151N, this effect was largely attributed to 
its higher Kd for a correct nucleotide when a mismatched template-primer is used as substrate.  
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These effects are similar to those reported here for V75I.  However, the catalytic efficiency of 
Q151N is largely reduced in comparison with the wild-type enzyme,17,50 suggesting that this 
mutation is unlikely to appear in vivo, due to its detrimental effect on dNTP binding.  In 
contrast, V75I and other mutants at this position retain significant DNA polymerase activity in 
incorporation assays carried out under different conditions (Tables 1 and 4 and in Figure 1).
These results were also consistent with the variability observed at Val-75 in vivo.  
Mutant virus carrying the drug-resistance-related mutations V75I and V75T were shown to 
replicate efficiently in various cell types.35,51  V75I emerges as a secondary mutation in HIV 
variants resistant to multiple dideoxynucleosides,31,32 and appeared as a compensatory mutation 
in virus carrying G190E, a substitution conferring resistance to several nonnucleoside RT 
inhibitors.34,52  In the case of multidrug-resistance, V75I appears together with Q151M and 
probably affects dNTP binding by altering the interaction of Gln-151 with the nitrogen base of 
the incoming dNTP, as well as other interactions within the core of the fingers subdomain (e.g. 
with the side chain of Phe-77).  On the other hand, its compensatory effect in virus carrying 
mutation G190E could be related to the positioning of the template-primer.  Although the 
peptide backbone of Val-75 interacts with the 5´ template overhang in the ternary complex of 
HIV-1 RT, we cannot rule out an indirect effect on Gln-151 and other residues in the dNTP 
binding site that could account for the observed differences in the fidelity of DNA synthesis.  
Materials and Methods
Reagents 
Stock solutions (100 mM) of dNTPs and [γ-32P]ATP were obtained from GE Healthcare. 
DNA oligonucleotides 21P (5´-ATACTTTAACCATATGTATCC-3´), PG5–25 (5´-
CCAGAATGCTGGTAGGGCTATACAT-3´), 31T (5´-
TTTTTTTTTAGGATACATATGGTTAAAGTAT-3´), and D2–47 (5´-
16
GGGATTAAATAAAATAGTAAGAATGTATAGCCCTACCAGCATTCTGG-3´) were 
obtained from Life Technologies. Oligonucleotides 21P and PG5-25 were labelled at their 5´ 
termini with [γ-32P]ATP and T4 polynucleotide kinase, and then annealed to their corresponding 
templates (31T and D2-47, respectively). Template-primer 31T/21P was used in rapid quench 
experiments, while D2-47/PG5-25 was used in steady state kinetic assays. All others reagents 
were purchased from Merck or Sigma.
Phage and bacterial strains
The bacteriophage M13mp2 was used to prepare the gapped duplex DNA substrate. M13 
phage was grown in the E. coli strain NR9099 [Δ(pro-lac), thi, ara, recA56/F´ (proAB, 
lacIqZΔM15)] to obtain the single-stranded and replicative DNA of M13. Electrocompetent E. 
coli strain MC1061 [hsdR, hsdM+, araD, Δ(ara, leu), Δ(lacIPOZY), galU, galK, strA] was 
used to generate the mutant phage. The α-complementation strain of E. coli, CSH50 [Δ(pro-lac), 
thi, ara, strA/F´ (proAB, lacIqZΔM15, traD36)], was used to visualize the phenotype of the 
mutant phage.
Mutagenesis, expression and purification of recombinant RTs 
Site-directed mutagenesis was carried out with the Quik-Change Site-Directed 
Mutagenesis kit (Stratagene) using plasmids pRT6 53 or p66RTB 54 as templates, and the 
mutagenic primers: 5´-CAGTACTAAATGGAGAAAATTAGCAGATTTCAGAGAAC-3´ and 
5´-GTTCTCTGAAATCTGCTAATTTTCTCCATTTAGTACTG-3´ for V75A, 5´-
CAGTACTAAATGGAGAAAATTATTCGATTTCAGAGAAC-3´ and 5´-
GTTCTCTGAAATCGAATAATTTTCTCCATTTAGTACTG-3´ for V75F, 5´-
CAGTACTAAATGGAGAAAATTAATAGATTTCAGAGAAC-3´ and 5´-
GTTCTCTGAAATCTATTAATTTTCTCCATTTAGTACTG-3´ for V75I, 5´-
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CAGTACTAAATGGAGAAAATTACTAGATTTCAGAGAAC-3´ and 5´-
GTTCTCTGAAATCTAGTAATTTTCTCCATTTAGTACTG-3´ for V75L, 5´-
CAGTACTAAATGGAGAAAATTAATGGATTTCAGAGAAC-3´ and 5´-
GTTCTCTGAAATCCATTAATTTTCTCCATTTAGTACTG-3´ for V75M, 5´-
CAGTACTAAATGGAGAAAATTATCAGATTTCAGAGAAC-3´ and 5´-
GTTCTCTGAAATCTGATAATTTTCTCCATTTAGTACTG-3´ for V75S, 5´-
CAGTACTAAATGGAGAAAATTAACAGATTTCAGAGAAC-3´ and 5´-
GTTCTCTGAAATCTGTTAATTTTCTCCATTTAGTACTG-3´ for V75T (relevant codons 
underlined), by following the manufacturer’s instructions.  After mutagenesis, the RT-coding 
regions were sequenced.  Then, inserts containing the appropriate mutations were cloned in the 
p51 expression vector pT51H, by following previously described procedures.9,55
RTs were purified as described, after independent expression of their subunits (p66 and 
p51),44,56 using the constructs derived from pRT6 and pT51H. The 51 kDa subunit was obtained 
with an extension of 14 amino acid residues at its N-terminal end, which includes six 
consecutive histidine residues to facilitate its purification by metal chelate affinity 
chromatography. For those experiments requiring high concentrations of HIV-1 RT (i.e. 
determination of pre-steady-state kinetic parameters), RT expression and purification was 
performed with modified versions of plasmid p66RTB,57 as previously described.54 RT p66 
subunits carrying a His6 tag at their C-terminus were co-expressed with HIV-1 protease in E. 
coli XL1 Blue to obtain p66/p51 heterodimers, which were later purified by ionic exchange 
followed by affinity chromatography.54,57 Enzymes were quantified by active site titration37
before biochemical studies.
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Extension of primers in the absence of one dNTP
The template/primer D2-47/PG5-25 was used to determine the extent of 
misincorporation in the absence of one dNTP. Prior to the elongation reaction, PG5-25 was 
labelled at its 5´ terminus with [γ-32P]ATP and T4 polynucleotide kinase, and annealed to the 
template (D2-47) in a solution containing 150 mM NaCl and 150 mM magnesium acetate.11  
Then, the template-primer was diluted 10-fold in 500 mM Hepes (pH 7.0), containing 150 mM 
NaCl and 150 mM magnesium acetate. Assays were carried out for 0 to 60 min at 37ºC with 24 
nM RT, in 10 μl of 50 mM Hepes (pH 7.0), 15 mM NaCl, 15 mM magnesium acetate, 130 mM 
KCH3COO, 1 mM DTT, 5% (w/v) polyethylene glycol, and dNTPs at a concentration of 500 
µM each (*: dATP, dCTP, dTTP; -A: dCTP, dTTP; -T: dATP, dCTP; and –C: dATP, dTTP).  
The template-primer concentration in the assay was 22.5 nM. At the end of the incubation 
period, the reactions were stopped by adding 4 μl of stop solution (10 mM EDTA in 90% 
formamide containing 3 mg/ml xylene cyanol FF and 3 mg/ml bromophenol blue) and incubated 
at 90º C for 10 min. Reaction products were separated in denaturing 20% polyacrylamide/8 M 
urea gels, and visualized by phosphorimaging with a BAS 1500 scanner (Fuji).
Steady-state kinetic assays
Fidelity assays were performed as previously described.58-60 Assays were carried out in 
10-12 μl of 50 mM Hepes (pH 7.0), 15 mM NaCl, 15 mM magnesium acetate, 130 mM 
KCH3COO, 1 mM DTT and 5% (w/v) polyethylene glycol 6000. The template-primer used in 
misinsertion fidelity assays was D2-47/PG5-25. For mispair extension fidelity assays, three 
additional primers were used instead of PG5-25 (i.e. PG5–25C, PG5–25G and PG5–25A). All 
of them were identical to PG5–25, but they had C, G, or A (instead of T), at their 3´ end. 
Template-primer concentrations were 30 nM in all assays.  Nucleotide concentrations in the 
range of 10 nM – 1 mM were used to measure dTTP incorporation, while incorrect dNTP 
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concentrations ranged from 0.1 to 10 mM in the assays.  For the extension of mismatched 
template-primers, dTTP concentrations used were in the range of 10 μM – 5 mM. The active 
enzyme concentration was around 6-10 nM. The rate of product formation was measured for 10-
12 different concentrations of each correct or incorrect dNTP. After incubation at 37ºC, products 
were heat-denatured, resolved in 20% polyacrylamide/8 M urea gels and quantified with a BAS 
1500 scanner (Fuji) using the program Tina version 2.09 (Raytest Isotopenmessegerate Gmbh 
Staubenhardt, Germany). The catalytic constants kcat and Km were determined after fitting the 
elongation data to the Michaelis-Menten equation.
Pre-steady-state kinetic assays
Pre-steady-state kinetic parameters for the incorporation of dTTP by wild-type and 
mutant HIV-1 RTs were determined with a rapid quench instrument (model QFM-400, Bio-
Logic Science Instruments, Claix, France) with reaction times ranging from 10 ms to 6 s.37
Reactions were performed by mixing 12 μl of a solution containing 50 nM (active sites) of HIV-
1 RT and 100 nM of the template/primer 31T/21P in RT buffer [50 mM Tris– HCl (pH 8.0), 50 
mM KCl, 0.05% (v/v) Triton X-100] with 12 μl of RT buffer containing different concentrations 
of dNTP in the presence of 12-18 mM MgCl2. At appropriate times, reactions were quenched 
with EDTA (0.3 M final concentration). For studying misinsertion and mismatched primer 
extension fidelity, reactions involving the incorporation of incorrect nucleotides and the mispair 
extension (i.e. the incorporation of dCTP and dGTP on 31T/21P or the extension of G:T, G:G 
and G:A mispairs) were conducted with excess concentrations of enzyme (120 nM) over the 
template–primer duplex (100 nM). These conditions were chosen to eliminate the influence of 
the enzyme turnover rate (kss), which interferes in the measurements of low incorporation rates. 
For mispair extension fidelity assays,61 three additional primers were used: 21PT, 21PG 
and 21PA. All of them were identical to 21P, but had T, G, or A (instead of C), at their 3´ 
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terminus. Misincorporation and mispair extension reactions were performed in the buffer 
conditions described above, using a rapid quench instrument. When the reaction times were 
longer than 8 s, the assays were carried out manually. The reaction products were separated on a 
20% (w/v) polyacrylamide/8 M urea gel, and quantified by phosphorimaging with a BAS 1500 
scanner (Fuji). The formation of product [P] over time was fitted with the burst equation:
[P]= A x [1-exp (-kobs x t)] + kss x t                                                                                 
where A is the amplitude of the burst, kobs is the apparent kinetic constant of formation of the 
phosphodiester bond, and kss is the enzyme turnover rate, i.e. the kinetic constant of the steady-
state linear phase. Data from single-turnover experiments were fitted to a single-exponential 
equation that measures the rate of dNTP incorporation (kobs) per given dNTP concentration 
([dNTP]). The dependence of kobs on [dNTP] is described by the hyperbolic equation:
kobs = kpol x [dNTP]/(Kd + [dNTP])                                                                                     
where Kd and kpol are the equilibrium constant and the catalytic rate constant of the dNTP for 
RT, respectively. Kd and kpol were determined from curve-fitting using Sigma Plot.
M13mp2 lacZα forward and reversion mutation assays
Mutation frequencies for wild-type and mutant HIV-1 RTs were determined as described 
previously.41 M13mp2 DNA containing a single-stranded gap of 361 nucleotides was prepared 
as described41 and used as a template/primer for fill-in DNA synthesis reactions by wild-type 
and mutant RTs. In the forward mutation assay, polymerase errors that inactivate the 
nonessential α-complementation activity of the lacZ gene in bacteriophage M13mp2 are scored 
as light blue or colourless plaques. In this assay, mutant phenotypes can be the result of 
nucleotide changes at 125 different sites in the lacZ gene. In the reversion mutation assay the 
starting DNA substrate contains an inactivating base-substitution in the lacZ gene.  Polymerase 
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errors that restore partial or full α-complementation activity to yield a blue plaque phenotype are 
scored.  Fill-in reactions were carried out with gapped M13mp2 DNA (50 ng), purified RT (100 
nM), and the four dNTPs (250 μM each) in 10 μl of 25 mM Tris-HCl (pH 8.0) buffer, 
containing 100 mM KCl, 2 mM DTT and 4 mM MgCl2.  Reactions were incubated for 30 min at 
37°C, and then stopped by adding 1 µl of 60 mM EDTA. Complete synthesis across the gapped 
region was confirmed by agarose gel electrophoresis.41 Two independent gap filling reactions 
were performed for RT proteins.  Reaction products were introduced into E. coli strain MC1061 
by electroporation. Transformed cells were plated to M9 plates containing 5-bromo-4-chloro-3-
indolyl-β-D-galactopyranoside (X-gal) and isopropyl-1-thio-β-D-galactopyranoside (IPTG) with 
CSH50 lawn cells. The mutation frequency was determined as the ratio of mutant plaques (light 
blue and colourless in the forward mutation assay, or blue in the reversion assay) to mutant plus 
wild type plaques (dark blue in the forward mutation assay or colourless in the reversion assay),
as described.41 The background mutation frequency was determined by electroporating unfilled 
gapped duplex and scoring for mutant plaques as described above. 
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FIGURE LEGENDS
Figure 1. Primer extension by wild-type and mutant RTs in assays containing a DNA template 
(D2-47) and lacking a complementary dNTP. Reactions were incubated for 5, 15, 30 and 60 
min, as shown. Lanes marked with an asterisk indicate that all three nucleotides are included in 
the dNTP mix. The lanes marked with -A, -C and -T represents the missing nucleotide from the 
dNTP mix in the respective set of experiments. P and F indicate the positions of the unextended 
primer and the fully-extended products, respectively.  Prominent bands at positions +4 and +7 
represent stop sites occurring after the incorporation of 4 and 7 nucleotides, respectively.
Arrows are used to indicate bands representing specific stops produced by Val-75 mutants.  
Boxes are used to highlight the differences between the wild-type RT and mutants V75I and 
V75T.
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Figure 2.  Nucleotide concentration dependence on the first-order rates for correct (dTTP), or 
incorrect (dCTP and dGTP) incorporation into DNA/DNA 31/21-mer.  (a) Pre-steady-state 
kinetics of nucleotide incorporation by wild-type HIV-1 RT. Preincubated solutions of RT (50 
nM) and [5'- 32P] 31/21-mer (100 nM) were mixed with increased concentrations of nucleotide 
in a buffer containing 12 mM Mg2+ to start the reactions. The reactions were quenched at the 
indicated times and analyzed in polyacrylamide gels. The solid lines represented the best fit of 
the data for dTTP incorporation to the burst equation (left panel).  Center and right panels show 
the kinetics of dCTP and dGTP incorporation under single turnover conditions (i.e. excess of RT 
over template-primer). In both cases, data were fit to a single exponential equation.  (b) The 
first-order rates measured above were plotted against the corresponding nucleotide 
concentration. The data were fit to a hyperbolic equation as described under “Materials and 
Methods”.  The solid lane represents the best fit of the data to the hyperbolic equation. (c)
Concentration dependence of dTTP (left), dCTP (centre) or dGTP (right) incorporation into the 
31T/21P template-primer by mutant RTs V75A (●), V75F (■) and V75I ( ). Incorporation rates
(kobs), obtained from the corresponding burst or single exponential equations (not shown), were 
plotted against the nucleotide concentrations, and the data were fitted to the hyperbolic equation 
to obtain Kd and kpol values. In all cases, kinetic parameters for correct nucleotide incorporations 
were determined in the presence of 12 mM Mg2+. Incorporation of dCTP and dGTP by mutants 
V75F and V75I was monitored in the presence of 18 mM Mg2+.
Figure 3.  Nucleotide concentration dependence on the first-order rates for dTTP incorporation 
into DNA/DNA 31/21-mers with G:T, G:G or G:A mismatches at their 3´ end.  (a), Pre-steady-
state kinetics of dTTP incorporation on a mismatched template-primer by wild-type HIV-1 RT.
Preincubated solutions of RT (120 nM) and [5'- 32P] 31/21-mer (100 nM) were mixed with 
increased concentrations of nucleotide in a buffer containing 12 mM Mg2+ to start the reactions. 
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The reactions were quenched at the indicated times and analyzed in polyacrylamide gels. The 
solid lines represented the best fit of the data to the single exponential equation.  (b), The first-
order rates (kobs) measured above were plotted against the corresponding nucleotide 
concentration. The data were fit to a hyperbolic equation as described under “Materials and 
Methods”.  The solid lane represents the best fit of the data to the hyperbolic equation. (c), 
Concentration dependence of dTTP incorporation into the template-primers 31T/21PT (left), 
31T/21PG (centre), and 31T/21PA (right) by mutant RTs V75A (●), V75F (■) and V75I ( ). 
First-order rates, obtained from the corresponding equations (not shown), were plotted against 
the nucleotide concentrations, and the data were fitted to the hyperbolic equation to obtain Kd
and kpol values.  Mispair extensions catalyzed by mutant V75A were carried out in the presence 
of Mg2+ at a 12 mM concentration, while reactions performed with V75F or V75I were done in 
the presence of 18 mM Mg2+.  Inhibition of the elongation reaction due to an excess of substrate 
was observed at dGTP concentrations above 12 mM with all RTs.  This effect was not 
neutralized by increasing the concentration of Mg2+.
Figure 4.  Interactions between the peptide backbone of Val-75 of HIV-1 RT and neighbouring 
residues. (a) View of the DNA polymerase site showing the location of the dsDNA template-
primer (template strand in red and primer strand in white), and the incoming dNTP (yellow).  
Blue and green ribbon representations are used to indicate the location of the 66-kDa and the 51-
kDa subunits of the RT, respectively. The β3-β4 hairpin loop (shown in orange) contains Val-
75, which is represented with a CPK model.  Location of Val-75 (yellow), Gln-151 (blue) and 
template nucleotide +1 (red) in the crystal structures of the ternary complex of HIV-1 
RT●DNA/DNA●dTTP (PDB file 1RTD)3 (b), and binary complexes of HIV-1 RT and dsDNA 
(c and d).  The structure shown in panel (c) corresponds to PDB file R0A, and contains a 5´ 
template overhang of 3 nucleotides,48 while in (d), the single-stranded template contains just one 
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nucleotide (PDB file 2HMI).46 Representative intramolecular distances (in Å) between peptide 
backbone groups in Val-75 and neighbouring residues are indicated.  Reported distances 
between the –CO– group of Val-75 and the template nucleotide correspond to positions N3 
(nitrogen base), C1’ (ribose), and the average distance to the five atoms in the ribose ring. 
Figure 5.  Effect of RT mutations on the fidelity of DNA synthesis. Misincorporation 
efficiencies (a) and mispair extension efficiencies (b) for the wild-type HIV-1 RT and mutants 
V75A, V75F and V75I, as determined in steady-state kinetic assays (left) and in pre-steady-state 
kinetic assays (right). 
Abbreviations and footnotes
Abbreviations used:  HIV-1, human immunodeficiency virus type-1; RT, reverse transcriptase; 
dsDNA, double-stranded DNA
Table 1. Steady-state kinetic parameters for dTTP incorporation of WT and mutant 
RTs.a
a D2-47/PG5-25 was used as the substrate. Data shown are the mean values ± standard 
deviation, obtained from a non-linear least squares fit of the kinetics data to the 
Michaelis-Menten equation, of a representative experiment. Each of the experiments 
was performed independently at least twice.  Inter-assay variability was below 20 %.
Enzyme
kcat
(min-1)
Km
(µM)
kcat/ Km
(µM-1 min-1)
WT 3.71 ± 0.08 0.0579 ± 0.009 64.07 ± 10.05
V75A 4.30 ± 0.18 0.156 ± 0.038 27.56 ± 6.81
V75F 4.87 ± 0.15 0.219 ± 0.045 22.23 ± 4.62
V75I 4.10 ± 0.15 0.153 ± 0.045 26.80 ± 7.94
V75L 4.67 ± 0.21 0.153 ± 0.041 30.52 ± 8.29
V75M 3.72 ± 0.06 0.115 ± 0.012 32.35 ± 3.41
V75S 5.49 ± 0.21 0.133 ± 0.034 41.28 ± 10.67
V75T 5.29 ± 0.19 0.168 ± 0.043 31.49 ± 8.14
Table 1
Table 2. Steady-state misinsertion fidelity of WT and mutant RTs, as obtained using the template primer D2-47/PG5-25.a 
 
 
 
a After formation of the RT-DNA/DNA complex, D2–47/PG5–25 elongation reactions were incubated at 37 °C for 20 s for dTTP, 45–90 s for 
dCTP and dGTP, and 60 min for dATP. Data shown are the mean values ± S.D., obtained from a nonlinear least-squares fit of the kinetics data to 
the Michaelis-Menten equation, of a representative experiment. Each of the assays was performed independently at least three times.  Inter-assay 
variability of the kinetic parameters was below 20 %. 
bfins = [ kcat(incorrect)/Km(incorrect)]/[kcat(correct)/Km(correct)], where incorrect nucleotides were dCTP, dGTP, or dATP, while the correct 
nucletotide was dTTP. 
cND, not determined. 
 
Enzyme 
 
Nucleotide 
kcat 
 (min-1) 
Km  
(µM) 
kcat/Km   
(µM-1 min-1) 
Misinsertion ratio 
  finsb 
 
dTTP 
 
3.71 ± 0.08 
 
0.0579 ± 0.009 
 
64.07 ± 10.05 
 
dCTP 1.50 ± 0.09 755 ± 135 (1.99 ± 0.37)×10-3 3.10×10-5 
dGTP 1.54 ± 0.11 542 ± 136 (2.84 ± 0.74)×10-3 4.43×10-5 
 
WT 
dATP (7.3 ± 0.9) ×10-3 NDc ND ND 
dTTP 4.30 ± 0.18 0.156 ± 0.038 27.56 ± 6.81  
dCTP 1.49 ± 0.10 298 ± 72 (5.00 ± 1.25)×10-3 1.81×10-4 
dGTP 1.19 ± 0.08 305 ± 97 (3.90  ±1.27)×10-3 1.41×10-4 
V75A 
dATP (11.1 ± 0.6) ×10-3 ND ND ND 
dTTP 4.87 ± 0.15 0.219 ± 0.045 22.23 ± 4.62  
dCTP 0.85 ± 0.08 711 ± 292 (1.19 ± 0.50)×10-3 5.35×10-5 
dGTP 1.27 ± 0.08 486 ± 133 (2.61 ± 1.58)×10-3 1.17×10-4 
V75F 
dATP ND ND ND ND 
dTTP 4.10 ± 0.15 0.153 ± 0.045 26.80 ± 7.94  
dCTP 1.30 ± 0.25 882 ± 145 (1.47 ± 0.37)×10-3 5.48×10-5 
dGTP 2.10 ± 0.43 808 ± 146 (2.59 ± 0.71)×10-3 9.66×10-5 
V75I 
dATP 
 
(5.8 ± 0.9) ×10-3 ND ND ND 
Table 2
 
Table 3. Steady-state mispair extension fidelity of WT and mutant RTs, as obtained using template-primer D2–47/PG5–25.a 
 
 
a After formation of the RT-DNA/DNA complex, mispair extension reactions were incubated at 37 °C for 20 s for the elongation of A:T and A:C 
mispairs, and 15–40 min for A:G and A:A mispairs. In all cases, we measured the incorporation of T opposite A at position +1. Data shown are 
the mean values ± S.D., obtained from a nonlinear least-squares fit of the kinetics data to the Michaelis-Menten equation, of a representative 
experiment. Each of the assays was performed independently at least three times.  Inter-assay variability of the kinetic parameters was below 20 
%. 
a The first base corresponds to the template and the second to the primer. 
b fext = [ kcat(mismatched)/Km(mismatched)]/ [kcat(matched)/Km(matched)] 
 
Enzyme 
Base pair at 
the 3’ endb 
kcat 
 (min-1) 
Km 
(µM) 
kcat/Km 
(µM-1 min-1) 
Mismatch extension ratio 
fextc 
 
A:C 
 
4.41 ± 0.12 
 
2.77 ± 0.46 
 
1.592 ± 0.268 
 
0.025  
A:G 0.113 ± 0.007 75.8 ± 20.1 (1.49 ± 0.40)×10-3 2.32 ×10-5 
 
WT 
A:A 0.081 ± 0.005 62.7 ± 14.4 (1.29 ± 0.31)×10-3 2.01×10-5 
A:C 4.35 ± 0.14 5.67 ± 0.72 0.767 ± 0.100 0.028  
A:G 0.155 ± 0.006 80.1 ± 14.4 (1.94 ± 0.36)×10-3 7.04×10-5 
V75A 
A:A 0.071 ± 0.004 51.3 ± 12.1 (1.38 ± 0.34)×10-3 5.00×10-5 
A:C 5.90 ± 0.37 37.6 ± 8.7 0.156 ± 0.038 7.02×10-3 
A:G 0.051 ± 0.005 368 ± 131 (1.39 ± 0.51) ×10-4 6.25×10-6 
V75F 
A:A 0.041 ± 0.003 282 ± 74 (1.45 ± 0.39)×10-4 6.52×10-6 
A:C 4.26 ± 0.21 32.3 ± 6.5 0.132 ± 0.027 4.93×10-3 
A:G 0.076 ± 0.003 374 ± 44 (2.03 ± 0.25)×10-4 7.57×10-6 
V75I 
A:A 
 
0.055 ± 0.005 342 ± 95 (1.61 ± 0.47)×10-4 6.01×10-6 
Table 3
Table 4. Pre-steady-state kinetic parameters of WT and mutants RTs for misincorporation.a
a The template-primer 21P/31T was used as the substrate. Data shown are the mean values ± standard deviation of a representative experiment. 
Each of the assays was performed independently at least twice. Inter-assay variability was below 20 %.
b fins = [ kpol(incorrect)/Kd(incorrect)]/[kpol(correct)/Kd(correct)], where incorrect nucleotides were dCTP or dGTP, while the correct nucleotide was
dTTP.
Enzyme Nucleotide
kpol
(s-1)
Kd
(µM)
kpol/Kd 
(µM-1 s-1)
Misinsertion ratio 
fins
b
dTTP 11.57 ± 0.49 13.40 ± 1.88 0.863 ± 0.126
dCTP 0.291 ± 0.052 7645 ± 2959 (3.80 ± 1.62)×10-5 4.40×10-5
WT
dGTP 0.289 ± 0.032 3435 ± 1099 (8.40 ± 2.84)×10-5 9.73×10-5
dTTP 15.23 ± 1.45 16.30 ± 4.96 0.934 ± 0.298
dCTP 0.178 ± 0.009 4170 ± 734 (4.26 ± 0.78)×10-5 4.58×10-5
V75A
dGTP 0.153 ± 0.008 2271 ± 446 (6.74 ± 1.37)×10-5 7.22×10-5
dTTP 8.36 ± 0.65 33.25 ± 6.91 0.251 ± 0.056
dCTP 0.057 ± 0.002 7067 ± 594 (8.06 ± 0.73)×10-6 3.22×10-5
V75F
dGTP 0.135 ± 0.025 11006 ± 3537 (1.23 ± 0.45)×10-5 4.90×10-5
dTTP 7.86 ± 0.88 12.07 ± 4.64 0.651 ± 0.261
dCTP 0.175 ± 0.023 16116  ± 3666 (1.08 ± 0.29)×10-5 1.66×10-5
V75I
dGTP 0.408 ± 0.041 12741 ± 1970 (3.20 ± 0.59)×10-5 4.92×10-5
Table 4
Table 5. Pre-steady-state kinetic parameters of WT and mutants RTs for mispair extension.a
a The template-primer 21P/31T was used as the substrate. Data shown are the mean values ± standard deviation of a representative experiment. 
Each of the assays was performed independently at least twice. Inter-assay variability was below 20 %.
b The first base corresponds to the template and the second to the primer.
c fext = [ kpol(mismatched)/Kd(mismatched)]/[kpol(matched)/Kd(matched)].
Enzyme
Base pair at 
the 3’ end b
kpol
(s-1)
Kd
(µM)
kpol/Kd 
(µM-1 s-1)
Mismatch extension ratio
fext
c
G:T 2.54 ± 0.13 2628 ± 252 (9.66 ± 1.05)×10-3 1.12×10-3
G:G 0.266 ± 0.020 1014 ± 188 (2.62 ± 0.52)×10-4 3.05×10-4
WT
G:A 0.016 ± 0.001 5110 ± 755 (3.09 ± 0.49)×10-6 3.59×10-6
G:T 1.07 ± 0.05 1199 ± 169 (8.93 ± 1.32)×10-4 9.56×10-4
G:G 0.213 ± 0.089 853 ± 94 (2.50 ± 1.08)×10-4 2.69×10-4
V75A
G:A 0.0172 ± 0.002 3086 ± 832 (5.56  ± 1.57)×10-6 5.98×10-6
G:T 1.31  ± 0.14 9076 ± 1795 (1.45  ±  0.32)×10-4 5.78×10-4
G:G 0.084 ± 0.009 5892 ± 1459 (1.42  ± 0.39)×10-5 5.65×10-5
V75F
G:A 0.0017 ± 0.0002 1372 ± 514 (1.24  ± 0.49)×10-6 4.94×10-6
G:T 2.15 ± 0.39 9539 ± 1571 (2.26 ± 0.42)×10-4 3.47×10-4
G:G 0.224 ± 0.027 5888 ± 1533 (3.81  ± 1.09)×10-5 5.86×10-5
V75I
G:A 0.0036 ± 0.0006 3987 ± 1632 (0.903  ± 0.399)×10-6 1.39×10-6
Table 5
Table 6. Accuracy of WT and mutants RTs in M13mp2 lacZα forward and reversion
mutation assays.
Enzyme Total plaques Mutant 
plaques
Mutant 
frequency 
(×10-4)
Fidelity
(fold 
increase)
M13mp2 lacZα Forward Mutation Assaya
WT 6736 139 206 -
V75A 5271 148 281 0.7
V75F 6157 69 112 1.8
V75I 6033 42 69.6 3.0
M13mp2 lacZα Reversion Mutation Assay
WT 1292640 35 27 -
V75I 4059250 32 7.8 3.5
a As a control, nucleotide sequencing of the entire 361-base pair lacZα gene obtained from M13mp2 DNA 
isolated from 5 mutant colonies of each DNA synthesis reaction was performed. All colonies contained 
single mutations within the lacZ target that produced gene inactivation.  Background mutant frequency 
for this assay was estimated to be around 5 x 10-4.
Table 6
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